|
|
||||||||
Original Report |
1 Department of Radiology, Vancouver Hospital and Health Sciences Centre UBC
Site, 2211 Wesbrook Mall, Vancouver, B. C., V6T 2B5 Canada.
2 Department of Neurology, Vancouver Hospital and Health Sciences Centre-UBC
Site, Vancouver, B. C., V6T 2B5 Canada.
Received June 10, 2002;
accepted after revision July 25, 2002.
Address correspondence to C. F. Keogh.
Abstract
|
|
|---|
CONCLUSION. Symmetric abnormality involving the cerebellar white matter and posterior limb of the internal capsule is characteristic of heroin vapor inhalation toxicity, although involvement may be more extensive, depending on the severity of the condition. MR imaging and CT appear to be essential for making this diagnosis because clinical history is often unreliable and findings at physical examination are nonspecific.
|
|
|---|
|
|
|---|
|
|
|
|
|
|
During the same week that the first patient was admitted, a 39-year-old man underwent MR imaging of the head for subacute onset of bradykinesia and ataxia. Although less dramatic, MR findings in this patient were remarkably similar to those of the first patient, with involvement of the cerebellar white matter, posterior limb of the internal capsule, and posterior cerebral white matter (Fig. 2A,2B,2C). The fluid-attenuated inversion recovery sequence (FLAIR) was the most sensitive for revealing the signal abnormality.
|
|
|
|
|
Regarding MR findings, specific questioning revealed that both men inhaled heroin vapor, a practice known as "chasing the dragon" or "chineseing" [2, 3]. The patients had indulged in this practice within the previous 3 weeks. The second patient was also taking methadone as part of a maintenance program.
Five weeks later, a 32-year-old man presented with dysarthria, bradykinesia, and ataxia. The patient was enrolled in a methadone program but had also inhaled heroin 2 weeks previously. CT and MR imaging showed abnormalities (Fig. 3A,3B) in a similar distribution as those of the other two patients, although not as extensive as those in the patient who ultimately died.
|
|
An autopsy was performed on the first patient, which revealed extensive spongiform degeneration of the white matter and formation of vacuoles in the same distribution as the MR abnormalities (Figs. 1G and 1H). These findings are characteristic of heroin inhalation toxicity as described by Wolters et al. [3].
|
|
|---|
Leukoencephalopathy due to inhalation of heroin pyrolysate was first described by researchers in The Netherlands in 1982 [3]. Clinically, the condition has three stages, progressing from cerebellar signs and motor restlessness to pyramidal and pseudobulbar signs and, in a minority of patients, to a terminal stage characterized by spasms, hypotonic paresis, and ultimately death [3]. Symmetric spongiform degeneration occurs, particularly in the cerebral and cerebellar white matter and in corticospinal and solitary tracts [3].
The MR imaging findings reflected this distribution, with symmetric high signal on T2-weighted and FLAIR sequences in these areas (Figs. 1A,1B,1C,1D,1E,1F,1G,1H and 2A,2B,2C). Involvement of the cerebellum and the posterior limb of the internal capsule, with sparing of the anterior limb, appears to be a characteristic finding in this condition, helping to distinguish it from other causes of leukoencephalopathy such as toluene toxicity or reversible posterior leukoencephalopathy [4, 5]. Although sparing of the subcortical white matter has not been previously described in the imaging literature, it would appear to be typical of this condition. The reason for this striking pattern of involvement is unknown. Kriegstein et al. [2] have shown reduced N-acetyl aspartate and increased cerebral lactate on proton MR spectroscopy in this condition, postulating that these findings reflect mitochondrial toxicity [2].
The particular chemical that causes heroin inhalation toxicity is unknown but is believed to be an occasional impurity that is activated by heating the drug over the aluminium foil.
In our study, all three patients had a definite history of chasing the dragon. Within the following month, two additional patients presented with similar imaging findings. Both patients were known to smoke crack cocaine, but further details could not be obtained. One patient was unresponsive on admission and subsequently died, and the other fled the emergency room after undergoing CT. These additional two patients may also have been dragon chasers, or alternatively, the toxic agent may be an impurity that can be added to heroin or cocaine and is only activated by heating. Unfortunately, samples of the drugs could not be obtained.
Heroin use and intoxication are associated with a number of other effects on the central nervous system, including hypoxic brain injury, transverse myelitis, and brain abscess. The imaging features of these manifestations, however, are nonspecific with regard to cause. Treatment is primarily supportive, although it has been suggested that coenzyme Q and vitamin supplements may be of benefit [2].
In summary, we presented three dramatic cases of toxic leukoencephalopathy related to heroin vapor inhalation. The condition involves the cerebral and cerebellar tracts, with characteristic involvement of the cerebellar and posterior cerebral white matter and the posterior limb of the internal capsule. Because of the illicit nature of the toxin and the variable, nonspecific clinical features, imaging, in particular MR imaging, is invaluable in making the diagnosis. Proton MR spectroscopy is not essential for the diagnosis but may help to elucidate the nature of the condition in the future. With changing practices of drug use, in part to avoid the risks of IV administration, further examples of this condition will likely be encountered.
Acknowledgments
We thank P. Chipperfield, T. Hurwitz, and D. Johnston for their information
and advice regarding the patients and G. R. W. Moore for pathologic
correlation.
|
|
|---|
This article has been cited by other articles:
![]() |
A. M. McKinney, S. A. Kieffer, R. T. Paylor, K. S. SantaCruz, A. Kendi, and L. Lucato Acute Toxic Leukoencephalopathy: Potential for Reversibility Clinically and on MRI With Diffusion-Weighted and FLAIR Imaging Am. J. Roentgenol., July 1, 2009; 193(1): 192 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Shprecher, K. M. Flanigan, A. G. Smith, S. M. Smith, T. Schenkenberg, and J. Steffens Clinical and Diagnostic Features of Delayed Hypoxic Leukoencephalopathy J Neuropsychiatry Clin Neurosci, November 1, 2008; 20(4): 473 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Martin, R. A. Hurley, and K. H. Taber Is Opiate Addiction Associated With Longstanding Neurobiological Changes? J Neuropsychiatry Clin Neurosci, August 1, 2007; 19(3): 242 - 248. [Full Text] [PDF] |
||||
![]() |
I. G. Hagan and K. Burney Radiology of Recreational Drug Abuse RadioGraphics, July 1, 2007; 27(4): 919 - 940. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Molloy, C. Soh, and T.L. Williams Reversible delayed posthypoxic leukoencephalopathy. AJNR Am. J. Neuroradiol., September 1, 2006; 27(8): 1763 - 1765. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-C. Chang, C.-P. Lo, H.-W. Kao, and C.-Y. Chen MRI features of spongiform leukoencephalopathy following heroin inhalation Neurology, August 8, 2006; 67(3): 504 - 504. [Full Text] [PDF] |
||||
![]() |
E Bartlett and D J Mikulis Chasing "chasing the dragon" with MRI: leukoencephalopathy in drug abuse Br. J. Radiol., November 1, 2005; 78(935): 997 - 1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Ryan, F M Molloy, M A Farrell, and M Hutchinson Fatal toxic leukoencephalopathy: clinical, radiological, and necropsy findings in two patients J. Neurol. Neurosurg. Psychiatry, July 1, 2005; 76(7): 1014 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Halloran, S. Ifthikharuddin, and L. Samkoff Leukoencephalopathy from "chasing the dragon" Neurology, May 24, 2005; 64(10): 1755 - 1755. [Full Text] [PDF] |
||||
![]() |
K. Okamoto, S. Tokiguchi, T. Furusawa, K. Ishikawa, A. F. Quardery, S. Shinbo, and K. Sasai MR Features of Diseases Involving Bilateral Middle Cerebellar Peduncles AJNR Am. J. Neuroradiol., November 1, 2003; 24(10): 1946 - 1954. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |